|
PARP9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6278089987054E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7414737147069E-12 |
| Normal-vs-Stage2 |
8.13040000000598E-05 |
| Normal-vs-Stage3 |
4.26659818586472E-11 |
| Normal-vs-Stage4 |
3.72039999918528E-08 |
| Stage1-vs-Stage2 |
5.465600E-01 |
| Stage1-vs-Stage3 |
3.492200E-01 |
| Stage1-vs-Stage4 |
1.757410E-01 |
| Stage2-vs-Stage3 |
2.595600E-01 |
| Stage2-vs-Stage4 |
1.330840E-01 |
| Stage3-vs-Stage4 |
5.145000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62536650805123E-12 |
| Normal-vs-AfricanAmerican |
8.438800E-04 |
| Normal-vs-Asian |
1.392610E-04 |
| Caucasian-vs-AfricanAmerican |
5.210300E-02 |
| Caucasian-vs-Asian |
6.516200E-01 |
| AfricanAmerican-vs-Asian |
1.993590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80488957113312E-12 |
| Normal-vs-Female |
2.88657986402541E-15 |
| Male-vs-Female |
4.866500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.842700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.74593672852552E-12 |
| Normal-vs-Age(61-80Yrs) |
2.1298518504409E-12 |
| Normal-vs-Age(81-100Yrs) |
2.539100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.603600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.919000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.293200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.323200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.156200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.610200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.4619000000008E-05 |
| Normal-vs-Grade 2 |
7.36188887628941E-13 |
| Normal-vs-Grade 3 |
4.08950651120676E-12 |
| Normal-vs-Grade 4 |
1.11520000012355E-07 |
| Grade 1-vs-Grade 2 |
9.450600E-01 |
| Grade 1-vs-Grade 3 |
9.012200E-01 |
| Grade 1-vs-Grade 4 |
4.219600E-01 |
| Grade 2-vs-Grade 3 |
8.762400E-01 |
| Grade 2-vs-Grade 4 |
2.053200E-01 |
| Grade 3-vs-Grade 4 |
1.796430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63968838506889E-12 |
| Normal-vs-ccB subtype |
2.10620410001638E-11 |
| ccA subtype-vs-ccB subtype |
6.032800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7107426586449E-12 |
| Normal-vs-N1 |
6.777900E-03 |
| N0-vs-N1 |
2.410000E-01 |
|
|
